SA
Sumalatha Ambarapu
About Sumalatha Ambarapu
Data last updated:
Sumalatha Ambarapu is a Director at Hatri Pharma Private Limited (since 2023). The company operates in Pharma. Hatri Pharma Private Limited reported revenue of ₹71.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Aug 2023 | 2010 | ₹71.7 Lakh (FY 2025) | Active |
Board colleagues of Sumalatha Ambarapu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohan Reddy Enaganuri | 02720838 | Hatri Pharma Private Limited | Director |
| Rebala Rupakala | 07623584 | Hatri Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sumalatha Ambarapu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sumalatha Ambarapu
Sumalatha Ambarapu currently holds 1 directorship: Hatri Pharma Private Limited (Director, since 09 Aug 2023, revenue ₹71.7 Lakh (FY 2025)).
Sumalatha Ambarapu was first appointed on 09 Aug 2023 as Director at Hatri Pharma Private Limited.
The current boards of Sumalatha Ambarapu's companies include Mohan Reddy Enaganuri (Hatri Pharma Private Limited), Rebala Rupakala (Hatri Pharma Private Limited).